Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Vertigoheel promotes rodent cognitive performance in multiple memory tests.
Front Neurosci
May 2023
Heel GmbH, Baden-Baden, Germany.
Introduction: Cognitive impairment associated with old age or various brain disorders may be very disabling for affected individuals, placing their carers and public health services under considerable stress. The standard-of-care drugs produce only transient improvement of cognitive impairment in older people, so the search for novel, safe and effective therapeutics that would help to reverse or delay cognitive impairment is warranted. Repurposing pharmacological therapies with well-established safety record for additional indications is a promising recent trend in drug development.
View Article and Find Full Text PDFA Return to Work Program for an Employee With Resolving Vertigo.
Workplace Health Saf
January 2017
1 California State University, Monterey Bay.
Vertigo is a disorder that affects equilibrium. Symptoms include a loss of balance with nausea and vomiting. Employees diagnosed with vertigo can return to work safely; however, they may need workplace restrictions and accommodation as symptoms may persist for months.
View Article and Find Full Text PDFWhat the ancient Greeks and Romans knew (and did not know) about seasickness.
Neurology
February 2016
From the Institute for Clinical Neurosciences (D.H., J.B., T.B.), German Center for Vertigo and Balance Disorders (D.H., T.B.), and Institute for Classical Philology (B.K.), Ludwig-Maximilians University, Munich; and Werl (H.O.), Germany.
Objective: To find and analyze descriptions in ancient Greek and Roman literature that reveal what was known at the time about seasickness.
Methods: A systematic search was made in the original literature beginning in the Greek period with Homer in ca 800 bc and extending up to Aetios Amidenos in the late Roman period in ca 600 ad.
Results: Rough seas and unpleasant odors were recognized as the major triggers; susceptibility was greater in persons not adapted to sea travel, of a labile mental state, or with anxiety; nausea, emesis, vertigo, anorexia, faintness, apathy, headache, and impending doom were frequently reported symptoms.
Which medication do I need to manage dizzy patients?
Acta Otolaryngol
March 2011
Institute of Clinical Neurosciences, University of Munich, Germany.
Vertigo and dizziness are not independent disease entities, but instead symptoms of various diseases. Accordingly, a variety of treatment approaches are required. Here we review the most relevant drugs for managing dizziness, vertigo, and nystagmus syndromes.
View Article and Find Full Text PDFPharmacokinetics and pharmacodynamics in clinical use of scopolamine.
Ther Drug Monit
October 2005
Institute of Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
The alkaloid L-(-)-scopolamine [L-(-)-hyoscine] competitively inhibits muscarinic receptors for acetylcholine and acts as a nonselective muscarinic antagonist, producing both peripheral antimuscarinic properties and central sedative, antiemetic, and amnestic effects. The parasympatholytic scopolamine, structurally very similar to atropine (racemate of hyoscyamine), is used in conditions requiring decreased parasympathetic activity, primarily for its effect on the eye, gastrointestinal tract, heart, and salivary and bronchial secretion glands, and in special circumstances for a CNS action. Therefore, scopolamine is most suitable for premedication before anesthesia and for antiemetic effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!